Hidroxicloroquina (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hidroxicloroquina" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

14doi.org

2^nd place

4^th place

8nih.gov

4^th place

8^th place

7worldcat.org

5^th place

1drugs.com

399^th place

289^th place

1web.archive.org

1^st place

1anvisa.gov.br

low place

424^th place

1sciencedirect.com

149^th place

155^th place

1nature.com

234^th place

190^th place

1scielo.br

1,606^th place

44^th place

1oup.com

485^th place

414^th place

1google.com.br

622^nd place

10^th place

1handle.net

102^nd place

459^th place

1pdr.net

low place

1webmd.com

1,169^th place

809^th place

1koreabiomed.com

low place

1wanfangdata.com.cn

low place

1medrxiv.org

low place

1pubpeer.com

low place

1bbc.com

20^th place

25^th place

1globo.com

62^nd place

2^nd place

1poder360.com.br

5,467^th place

145^th place

1springer.com

274^th place

339^th place

1hopkinsguides.com

low place

1nytimes.com

7^th place

14^th place

1recoverytrial.net

low place

1plos.org

2,112^th place

848^th place

1cnnbrasil.com.br

3,706^th place

107^th place

anvisa.gov.br

portal.anvisa.gov.br

ANVISA. Nota Técnica sobre Cloroquina e Hidroxicloroquina. Acesso em 21 de março de 2020

bbc.com

«Cloroquina 'une' Bolsonaro e Maduro em meio à pandemia de coronavírus». BBC News Brasil. Consultado em 13 de dezembro de 2021

cnnbrasil.com.br

«OMS: Hidroxicloroquina não funciona contra Covid-19 e pode causar efeito adverso». CNN Brasil. Consultado em 27 de agosto de 2021

doi.org

dx.doi.org

Cortegiani, Andrea; Ingoglia, Giulia; Ippolito, Mariachiara; Giarratano, Antonino; Einav, Sharon (10 de março de 2020). «A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19». Journal of Critical Care. ISSN 0883-9441. doi:10.1016/j.jcrc.2020.03.005
Axfors, Cathrine; Schmitt, Andreas M.; Janiaud, Perrine; van’t Hooft, Janneke; Abd-Elsalam, Sherief; Abdo, Ehab F.; Abella, Benjamin S.; Akram, Javed; Amaravadi, Ravi K. (15 de abril de 2021). «Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials». Nature Communications (em inglês) (1). 2349 páginas. ISSN 2041-1723. doi:10.1038/s41467-021-22446-z. Consultado em 6 de maio de 2021
Flint, Julia; Panchal, Sonia; Hurrell, Alice; van de Venne, Maud; Gayed, Mary; Schreiber, Karen; Arthanari, Subha; Cunningham, Joel; Flanders, Lucy; Moore, Louise; Crossley, Amy (1 de setembro de 2016). «BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding – Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids». Rheumatology. 55 (9): 1693–1697. ISSN 1462-0324. doi:10.1093/rheumatology/kev404
Steere, AC; Angelis, SM (outubro de 2006). «Therapy for Lyme Arthritis: Strategies for the Treatment of Antibiotic-refractory Arthritis». Arthritis and Rheumatism. 54 (10): 3079–86. PMID 17009226. doi:10.1002/art.22131
Wang, Shi-Qin; Zhang, Li-Wei; Wei, Pan; Hua, Hong (12 de maio de 2017). «Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis». BMC Musculoskeletal Disorders. 18. ISSN 1471-2474. PMC 5427554. PMID 28499370. doi:10.1186/s12891-017-1543-z
Marmor, MF; Kellner, U; Lai, TYY; Lyons, JS; Mieler, WF (fevereiro de 2011). «Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy». Ophthalmology. 118 (2): 415–22. PMID 21292109. doi:10.1016/j.ophtha.2010.11.017
Yao, Xueting; Ye, Fei; Zhang, Miao; Cui, Cheng; Huang, Baoying; Niu, Peihua; Liu, Xu; Zhao, Li; Dong, Erdan; Song, Chunli; Zhan, Siyan (9 de março de 2020). «In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)». Clinical Infectious Diseases. ISSN 1537-6591. PMID 32150618. doi:10.1093/cid/ciaa237
Sahraei Z, Shabani M, Shokouhi S, Saffaei A. Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine. Int J Antimicrob Agents. 2020 Mar 16:105945. doi:10.1016/j.ijantimicag.2020.105945 Predefinição:Pmid
«Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story». Applied Microbiology and Biotechnology. 2021. doi:10.1007/s00253-021-11094-4
Singh, Bhagteshwar; Ryan, Hannah; Kredo, Tamara; Chaplin, Marty; Fletcher, Tom (12 de fevereiro de 2021). «Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19». Cochrane Database of Systematic Reviews (2). ISSN 1465-1858. PMC 8094389. PMID 33624299. doi:10.1002/14651858.cd013587.pub2. Consultado em 27 de agosto de 2021
«The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials». PLOS ONE. 2021. doi:10.1371/journal.pone.0244778

doi.org

LACAVA, Augusto Cézar. Complicações oculares da terapêutica com a cloroquina e derivados. Arq. Bras. Oftalmol., São Paulo , v. 73, n. 4, p. 384-389, Aug. 2010 . Available from <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492010000400019&lng=en&nrm=iso>. access on 22 Mar. 2020. https://doi.org/10.1590/S0004-27492010000400019.
Liu, J., Cao, R., Xu, M. et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 6, 16 (2020). https://doi.org/10.1038/s41421-020-0156-0
Singh, Bhagteshwar; Ryan, Hannah; Kredo, Tamara; Chaplin, Marty; Fletcher, Tom (12 de fevereiro de 2021). «Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19». Cochrane Database of Systematic Reviews (2). ISSN 1465-1858. PMC 8094389. PMID 33624299. doi:10.1002/14651858.cd013587.pub2. Consultado em 27 de agosto de 2021

drugs.com

«Hydroxychloroquine Sulfate Monograph for Professionals». The American Society of Health-System Pharmacists. 20 de março de 2020. Consultado em 20 de março de 2020. Cópia arquivada em 20 de março de 2020

globo.com

g1.globo.com

«Trump defende hidroxicloroquina e se queixa de popularidade de Fauci». G1. Consultado em 27 de agosto de 2021

google.com.br

books.google.com.br

Browning, David J. Hydroxychloroquine and Chloroquine Retinopathy. Springer: New York, 2014

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO

hopkinsguides.com

Avdic, Edina. "Hydroxychloroquine". Johns Hopkins ABX Guide

koreabiomed.com

«Physicians work out treatment guidelines for coronavirus». Korea Biomedical Review. 13 de fevereiro de 2020. Consultado em 18 de março de 2020

medrxiv.org

«Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial»

nature.com

Axfors, Cathrine; Schmitt, Andreas M.; Janiaud, Perrine; van’t Hooft, Janneke; Abd-Elsalam, Sherief; Abdo, Ehab F.; Abella, Benjamin S.; Akram, Javed; Amaravadi, Ravi K. (15 de abril de 2021). «Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials». Nature Communications (em inglês) (1). 2349 páginas. ISSN 2041-1723. doi:10.1038/s41467-021-22446-z. Consultado em 6 de maio de 2021

nih.gov

ncbi.nlm.nih.gov

Flach, AJ (2007). «Improving the Risk-benefit Relationship and Informed Consent for Patients Treated with Hydroxychloroquine». Transactions of the American Ophthalmological Society. 105: 191–94; discussion 195–97. PMC 2258132. PMID 18427609
Steere, AC; Angelis, SM (outubro de 2006). «Therapy for Lyme Arthritis: Strategies for the Treatment of Antibiotic-refractory Arthritis». Arthritis and Rheumatism. 54 (10): 3079–86. PMID 17009226. doi:10.1002/art.22131
Wang, Shi-Qin; Zhang, Li-Wei; Wei, Pan; Hua, Hong (12 de maio de 2017). «Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis». BMC Musculoskeletal Disorders. 18. ISSN 1471-2474. PMC 5427554. PMID 28499370. doi:10.1186/s12891-017-1543-z
Marmor, MF; Kellner, U; Lai, TYY; Lyons, JS; Mieler, WF (fevereiro de 2011). «Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy». Ophthalmology. 118 (2): 415–22. PMID 21292109. doi:10.1016/j.ophtha.2010.11.017
Yao, Xueting; Ye, Fei; Zhang, Miao; Cui, Cheng; Huang, Baoying; Niu, Peihua; Liu, Xu; Zhao, Li; Dong, Erdan; Song, Chunli; Zhan, Siyan (9 de março de 2020). «In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)». Clinical Infectious Diseases. ISSN 1537-6591. PMID 32150618. doi:10.1093/cid/ciaa237
Singh, Bhagteshwar; Ryan, Hannah; Kredo, Tamara; Chaplin, Marty; Fletcher, Tom (12 de fevereiro de 2021). «Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19». Cochrane Database of Systematic Reviews (2). ISSN 1465-1858. PMC 8094389. PMID 33624299. doi:10.1002/14651858.cd013587.pub2. Consultado em 27 de agosto de 2021

covid19treatmentguidelines.nih.gov

«Chloroquine or Hydroxychloroquine». COVID-19 Treatment Guidelines. National Institutes of Health. Consultado em 14 de fevereiro de 2021

dailymed.nlm.nih.gov

,«Plaquenil- hydroxychloroquine sulfate tablet». DailyMed. 3 de janeiro de 2020. Consultado em 20 de março de 2020

nytimes.com

Grady, Denise (3 de junho de 2020). «Malaria Drug Promoted by Trump Did Not Prevent Covid Infections, Study Finds». The New York Times (em inglês). ISSN 0362-4331. Consultado em 27 de agosto de 2021

oup.com

academic.oup.com

Flint, Julia; Panchal, Sonia; Hurrell, Alice; van de Venne, Maud; Gayed, Mary; Schreiber, Karen; Arthanari, Subha; Cunningham, Joel; Flanders, Lucy; Moore, Louise; Crossley, Amy (1 de setembro de 2016). «BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding – Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids». Rheumatology. 55 (9): 1693–1697. ISSN 1462-0324. doi:10.1093/rheumatology/kev404

pdr.net

«Plaquenil (hydroxychloroquine sulfate) dose, indications, adverse effects, interactions». pdr.net. Consultado em 19 de março de 2020

plos.org

journals.plos.org

«The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials». PLOS ONE. 2021. doi:10.1371/journal.pone.0244778

poder360.com.br

«Bolsonaro é maior influenciador da cloroquina no mundo, aponta levantamento». Poder360. 6 de junho de 2021. Consultado em 27 de agosto de 2021

pubpeer.com

«PubPeer comment»

recoverytrial.net

Horby, Peter; Landray, Martin (5 de junho de 2020). «No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 — RECOVERY Trial». www.recoverytrial.net. Consultado em 6 de junho de 2020

scielo.br

LACAVA, Augusto Cézar. Complicações oculares da terapêutica com a cloroquina e derivados. Arq. Bras. Oftalmol., São Paulo , v. 73, n. 4, p. 384-389, Aug. 2010 . Available from <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492010000400019&lng=en&nrm=iso>. access on 22 Mar. 2020. https://doi.org/10.1590/S0004-27492010000400019.

sciencedirect.com

Cortegiani, Andrea; Ingoglia, Giulia; Ippolito, Mariachiara; Giarratano, Antonino; Einav, Sharon (10 de março de 2020). «A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19». Journal of Critical Care. ISSN 0883-9441. doi:10.1016/j.jcrc.2020.03.005

springer.com

link.springer.com

«Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story». Applied Microbiology and Biotechnology. 2021. doi:10.1007/s00253-021-11094-4

wanfangdata.com.cn

subject.med.wanfangdata.com.cn

«A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)» (PDF)

web.archive.org

«Hydroxychloroquine Sulfate Monograph for Professionals». The American Society of Health-System Pharmacists. 20 de março de 2020. Consultado em 20 de março de 2020. Cópia arquivada em 20 de março de 2020

webmd.com

«Drugs & Medications». webmd.com. Consultado em 19 de março de 2020

worldcat.org

Cortegiani, Andrea; Ingoglia, Giulia; Ippolito, Mariachiara; Giarratano, Antonino; Einav, Sharon (10 de março de 2020). «A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19». Journal of Critical Care. ISSN 0883-9441. doi:10.1016/j.jcrc.2020.03.005
Axfors, Cathrine; Schmitt, Andreas M.; Janiaud, Perrine; van’t Hooft, Janneke; Abd-Elsalam, Sherief; Abdo, Ehab F.; Abella, Benjamin S.; Akram, Javed; Amaravadi, Ravi K. (15 de abril de 2021). «Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials». Nature Communications (em inglês) (1). 2349 páginas. ISSN 2041-1723. doi:10.1038/s41467-021-22446-z. Consultado em 6 de maio de 2021
Flint, Julia; Panchal, Sonia; Hurrell, Alice; van de Venne, Maud; Gayed, Mary; Schreiber, Karen; Arthanari, Subha; Cunningham, Joel; Flanders, Lucy; Moore, Louise; Crossley, Amy (1 de setembro de 2016). «BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding – Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids». Rheumatology. 55 (9): 1693–1697. ISSN 1462-0324. doi:10.1093/rheumatology/kev404
Wang, Shi-Qin; Zhang, Li-Wei; Wei, Pan; Hua, Hong (12 de maio de 2017). «Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis». BMC Musculoskeletal Disorders. 18. ISSN 1471-2474. PMC 5427554. PMID 28499370. doi:10.1186/s12891-017-1543-z
Yao, Xueting; Ye, Fei; Zhang, Miao; Cui, Cheng; Huang, Baoying; Niu, Peihua; Liu, Xu; Zhao, Li; Dong, Erdan; Song, Chunli; Zhan, Siyan (9 de março de 2020). «In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)». Clinical Infectious Diseases. ISSN 1537-6591. PMID 32150618. doi:10.1093/cid/ciaa237
Grady, Denise (3 de junho de 2020). «Malaria Drug Promoted by Trump Did Not Prevent Covid Infections, Study Finds». The New York Times (em inglês). ISSN 0362-4331. Consultado em 27 de agosto de 2021
Singh, Bhagteshwar; Ryan, Hannah; Kredo, Tamara; Chaplin, Marty; Fletcher, Tom (12 de fevereiro de 2021). «Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19». Cochrane Database of Systematic Reviews (2). ISSN 1465-1858. PMC 8094389. PMID 33624299. doi:10.1002/14651858.cd013587.pub2. Consultado em 27 de agosto de 2021